A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19
Public ClinicalTrials.gov record NCT05164133. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase Ib, Single-Arm, Open-Label Study Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab in Pediatric Patients Hospitalized With COVID-19
Study identification
- NCT ID
- NCT05164133
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Enrollment
- 2 participants
Conditions and interventions
Conditions
Interventions
- Tocilizumab Drug
Drug
Eligibility (public fields only)
- Age range
- Up to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 9, 2022
- Primary completion
- Mar 26, 2024
- Completion
- Mar 26, 2024
- Last update posted
- Apr 28, 2024
2022 – 2024
United States locations
- U.S. sites
- 7
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Reagan UCLA Medical Center | Los Angeles | California | 90095 | — |
| The University of Chicago | Chicago | Illinois | 60637 | — |
| Central Michigan University College of Medicine | Mount Pleasant | Michigan | 48858-3803 | — |
| Feinstein Institute for Medical Research | Manhasset | New York | 11030 | — |
| University Hospitals Cleveland Medical Center, Rainbow Babies and Childrens Hospital | Cleveland | Ohio | 44106-2624 | — |
| UT Physicians - Pediatric Center - Texas Medical Center | Houston | Texas | 77030-3005 | — |
| University of Utah - PPDS | Salt Lake City | Utah | 84108-1287 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05164133, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 28, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05164133 live on ClinicalTrials.gov.